13 research outputs found

    Stage-Specific Pathways of Leishmania infantum chagasi Entry and Phagosome Maturation in Macrophages

    Get PDF
    The life stages of Leishmania spp. include the infectious promastigote and the replicative intracellular amastigote. Each stage is phagocytosed by macrophages during the parasite life cycle. We previously showed that caveolae, a subset of cholesterol-rich membrane lipid rafts, facilitate uptake and intracellular survival of virulent promastigotes by macrophages, at least in part, by delaying parasitophorous vacuole (PV)-lysosome fusion. We hypothesized that amastigotes and promastigotes would differ in their route of macrophage entry and mechanism of PV maturation. Indeed, transient disruption of macrophage lipid rafts decreased the entry of promastigotes, but not amastigotes, into macrophages (P<0.001). Promastigote-containing PVs were positive for caveolin-1, and co-localized transiently with EEA-1 and Rab5 at 5 minutes. Amastigote-generated PVs lacked caveolin-1 but retained Rab5 and EEA-1 for at least 30 minutes or 2 hours, respectively. Coinciding with their conversion into amastigotes, the number of promastigote PVs positive for LAMP-1 increased from 20% at 1 hour, to 46% by 24 hours, (P<0.001, Chi square). In contrast, more than 80% of amastigote-initiated PVs were LAMP-1+ at both 1 and 24 hours. Furthermore, lipid raft disruption increased LAMP-1 recruitment to promastigote, but not to amastigote-containing compartments. Overall, our data showed that promastigotes enter macrophages through cholesterol-rich domains like caveolae to delay fusion with lysosomes. In contrast, amastigotes enter through a non-caveolae pathway, and their PVs rapidly fuse with late endosomes but prolong their association with early endosome markers. These results suggest a model in which promastigotes and amastigotes use different mechanisms to enter macrophages, modulate the kinetics of phagosome maturation, and facilitate their intracellular survival

    Rab5 accumulates near amastigotes.

    No full text
    <p>Bone marrow macrophages were infected with LcJ parasites as described. In the initial 30 min. of infection, Rab5 associates with amastigotes (<b>A</b>), but not with promastigotes (<b>B</b>). The percentage of promastigotes or amastigotes associating with Rab5 was quantified for 56 promastigotes and 111 amastigotes (<b>C</b>). Differences were statistically significant (p<0.005, Chi Square). Blue: actin; Green: CFSE-stained parasites, Red: Rab-5. Yellow indicates Rab-5/parasite co-localization. Scale bar = 10 µm.</p

    Transient disruption of macrophage lipid rafts accelerates LAMP-1 fusion with promastigote compartments.

    No full text
    <p>Macrophages were either left untreated as a control (<b>A</b>) or treated with 10 mM MβCD for 1 h (<b>B</b>) prior to infection with LcJ promastigotes. After 1 h, samples were fixed and stained for confocal microscopy. Tight, LAMP-1 negative or spacious, LAMP-1+ compartments are marked by wands or arrows, respectively. Data shown are representative of three independent experiments. Blue: TOPRO-3 stained DNA, Red: LAMP-1. Scale bar = 10 µm. (<b>C</b>) Amongst 487 intracellular promastigotes examined, the proportion residing in LAMP-1 negative versus LAMP-1+ compartments was significant (P = <0.001, Chi square).</p

    Cholesterol facilitates the entry and intracellular survival of promastigotes.

    No full text
    <p>Bone marrow macrophages were either left untreated as a control (open bars) or treated with 10 mM for 1 h (solid bars) to transiently deplete cell membrane cholesterol prior to infection. Separate experiments were performed for wild-type and LcJ promastigotes as well as for non-opsonized and 5% A/J serum opsonized parasites. At the indicated times, cells were fixed and stained with Wright-Giemsa and parasite load was assessed by microscopy. Data indicate parasites per 100 macrophages for wild-type metacyclic (<b>A</b> and <b>B</b>) and LcJ (<b>C</b> and <b>D</b>) promastigotes and are the means ± SE of 3 repeats, in triplicates (non-opsonized) or duplicate conditions (serum opsonized). Statistical analysis, (t-test), * P = <0.05, **P = <0.001.</p

    Parasitophorous vacuoles containing promastigotes and amastigotes recruit LAMP-1 with different kinetics.

    No full text
    <p>Macrophages were infected with <i>L. i. chagasi</i> metacyclic promastigotes (<b>A</b> and <b>C</b>) or hamster-derived amastigotes (<b>B</b> and <b>D</b>). Samples were fixed, stained and examined by confocal microscopy after 1 h (<b>A</b> and <b>B</b>) or 24 h (<b>C</b> and <b>D</b>). Images show CFSE-stained parasites in green and LAMP-1 in red. Bright green, LAMP-1-negative amastigotes are marked with a wand, and dim, LAMP-1+ amastigotes are indicated by arrows (<b>B</b>). DIC: differential interference contrast. Scale bar = 5 µm. Images are representative of multiple cells in five replicate experiments. Panels <b>E</b> and <b>F</b> demonstrate graphically the proportions of metacyclic promastigotes (panel <b>E</b>) or hamster-derived amastigotes (panel <b>F</b>) residing in LAMP-1+ or LAMP-1-negative compartments at 1 h or 24 h after parasite inoculation. Numbers were derived from examining 194 promastigotes and 340 amastigotes. Differential distribution of LAMP-1 in promastigote PVs at the two time points (panel <b>E</b>) was statistically significant (P<0.001, Chi square). In contrast, there was no difference between the distribution of LAMP-1 in amastigote PVs at the two time points (panel <b>F</b>), (p = NS, Chi square).</p

    Amastigotes, but not promastigotes retain EEA-1 during infection.

    No full text
    <p>Bone marrow macrophages were infected with either LcJ promastigotes (<b>A</b>, <b>C</b>, and <b>E</b>) or LcJ amastigotes (<b>B</b>, <b>D</b> and <b>F</b>) as described. Samples were fixed, stained and examined by confocal microscopy at 5 min. (<b>A</b> and <b>B</b>), 30 min. (<b>C</b> and <b>D</b>), or 2 h (<b>E</b> and <b>F</b>) after infection. Representative parasites associated with EEA-1 are indicated by arrows, and representative parasites not associated with EEA-1 are marked by wands. Panels <b>A</b>, <b>C</b> and <b>E</b> demonstrate a lack of colocalization of promastigotes with EEA-1. Panel <b>B</b> shows 6 several “dim” amastigotes that co-localized with EEA-1 and three “bright” amastigotes that did not. The one amastigote visualized in Panel <b>D</b> demonstrates co-localization. Panel <b>F</b> shows several clusters of amastigotes. Two out of 3 bright amastigotes and 13 out of 15 dim amastigotes colocalize with EEA-1. Blue: actin; Green: CFSE-stained parasites, Red: EEA-1. Yellow indicates EEA-1/parasite co-localization. Scale bar = 10 µm. Panels <b>G</b> and <b>H</b>: The percentage of promastigotes or amastigotes that associated with EEA-1 was quantified microscopically at either 5 min. (panel <b>G</b>: 119 promastigotes, 123 amastigotes) or 2 h (Panel <b>H</b>: 68 promastigotes, 159 amastigotes) after addition to macrophages. Statistical analysis showed the EEA-1 differential distribution between parasite stages was significant for each time point (p<0.0001 Chi Square).</p

    Differential EEA-1 accumulation between bright and dim amastigotes.

    No full text
    <p>Macrophages were incubated with CFSE-stained amastigotes (green) for 30 minutes at 37°C, 5% CO<sub>2</sub>. Cells were then stained with TO-PRO-3 (blue) which stained both macrophage and amastigote nuclei, and amastigote kinetoplasts, and stained for EEA-1 (Red). Panels <b>A</b> and <b>B</b> show examples of bright green (CFSE) amastigotes, most of which lacked EEA-1 co-localization (<b>A</b>) and “dim” (faintly or not green) amastigotes, most of which accumulated EEA-1 (<b>B</b>). The proportion of bright or “dim” amastigotes associated with EEA-1 was quantified in 227 amastigotes (<b>C</b>). Differences were statistically significant (p<0.0001, Chi square).</p

    Cholesterol depletion does not affect the entry of amastigotes.

    No full text
    <p>Bone marrow macrophages were either left untreated as a control (open bars) or treated with 10 mM MβCD for 1 h (solid bars) prior to infection. Separate experiments were performed for wild-type and LcJ amastigotes as well as for non-opsonized and 5% A/J serum opsonized parasites. Parasite load and intracellular survival was quantified as described. Data indicate parasites per 100 macrophages for wild-type (<b>A</b> and <b>B</b>) and LcJ (<b>C</b> and <b>D</b>) amastigotes and are the means ± SE of 3 repeats in triplicates (non-opsonized) or duplicate conditions (serum opsonized). Statistical analysis, (t-test), * P = <0.05, ** P = <0.001.</p

    Fusion of LAMP-1 with amastigotes compartments is independent of lipid raft integrity.

    No full text
    <p>Macrophages were either left untreated as a control (<b>A</b>) or treated with 10 mM MβCD for 1 h (<b>B</b>) and then infected with LcJ amastigotes for 1 h. Fixed cells were processed for confocal microscopy. LAMP-1+ compartments containing single and multiple parasites are indicated by arrows and wands, respectively. Blue: DNA, Red: LAMP-1. Scale bars, (A) = 5 µm; (B) = 10 µm. Panel (<b>C</b>) show a graphical representation of the numbers of amastigotes residing in LAMP-1 negative or LAMP-1+ compartments after examination of 461 or 530 amastigotes from control or treated macrophages, respectively. Differences were not statistically significant between the time points (p = NS, Chi square). Data were derived from three separate experiments.</p

    Crystal Structure of Arginase from Leishmania mexicana and Implications for the Inhibition of Polyamine Biosynthesis in Parasitic Infections

    No full text
    Arginase from parasitic protozoa belonging to the genus Leishmania is a potential drug target for the treatment of leishmaniasis because this binuclear manganese metalloenzyme catalyzes the first committed step in the biosynthesis of polyamines that enable cell growth and survival. The high resolution X-ray crystal structures of the unliganded form of Leishmania mexicana arginase (LmARG) and four inhibitor complexes are now reported. These complexes include the reactive substrate analogue 2(S)-amino-6-boronohexanoic acid (ABH) and the hydroxylated substrate analogue nor-Nω-hydroxy-l-arginine (nor-NOHA), which are the most potent arginase inhibitors known to date. Comparisons of the LmARG structure with that of the archetypal arginase, human arginase I, reveal that all residues important for substrate binding and catalysis are strictly conserved. However, three regions of tertiary structure differ between the parasitic enzyme and the human enzyme corresponding to the G62 – S71, L161 – C172, and I219 – V230 segments of LmARG. Additionally, variations are observed in salt link interactions that stabilize trimer assembly in LmARG. We also report biological studies in which we demonstrate that localization of LmARG to the glycosome, a unique subcellular organelle peculiar to Leishmania and related parasites, is essential for robust pathogenesis
    corecore